Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
AGNG
84
HOLDINGS
18%
ALSO IN HRTS
HRTS
42
HOLDINGS
36%
ALSO IN AGNG
SECTOR DRIFT (AGNG minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
NOVO NORDISK A/S-B | 3.9% | 5.4% | 3.9% |
 |
ELI LILLY & CO | 3.3% | 10.6% | 3.3% |
|
JOHNSON & JOHNSON | 2.9% | 3.7% | 2.9% |
|
MERCK & CO. INC. | 2.8% | 4.1% | 2.8% |
 |
ASTRAZENECA PLC | 2.8% | 4.0% | 2.8% |
AGNG Overweight Relative to HRTS
|
WELLTOWER, INC. | 3.2% |
|
VENTAS INC | 3.2% |
 |
ROCHE HOLDING AG-BR | 3.2% |
|
STRYKER CORP | 2.8% |
 |
UCB SA | 2.7% |
|
SANDOZ GROUP AG | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
|
ALCON, INC. | 2.3% |
 |
CELLTRION INC | 2.1% |
 |
HANSOH PHARMACEUTICAL GROUP COMPANY | 1.9% |
AGNG Underweight Relative to HRTS
|
ELI LILLY & CO | -7.3% |
|
UNITEDHEALTH GROUP INC | -5.5% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
THERMO FISHER SCIENTIFIC INC | -3.6% |
|
GILEAD SCIENCES INC | -3.4% |
|
NOVARTIS AG | -3.4% |
|
REVOLUTION MEDICINES, INC. | -3.1% |
|
VERTEX PHARMACEUTICALS INC | -2.9% |
|
BRIDGEBIO PHARMA, INC. | -2.6% |
|
ABBOTT LABORATORIES | -2.6% |